Results from previous studies and this case report indicate that maximum IOP occurs at approximately 8 weeks after injection of an Ozurdex implant. Although most patients can be managed by IOP-lowering medications, this case is unique because it is an example of repeated implants at approximately 4-month intervals that led to surgical intervention to control IOP. Evidence-based knowledge of Ozurdex as reviewed in this article will lead to better patient postoperative management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.